S100A10 and SP1 identified as ALS targets

DISEASE CATEGORY: Neurology

INDICATION: Amyotrophic lateral sclerosis (ALS)

Inhibiting the adaptor protein S100A10 or SP1, a

Read the full 145 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE